{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T01:56:34Z","timestamp":1781574994152,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004769","name":"Universit\u00e0 degli Studi di Pavia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004769","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) is characterized by a labile equilibrium between preload and afterload. A tailored approach to supporting medical therapy based on noninvasive parameters able to describe the properties of both heart and systemic vasculature, and their interactions is required. However, data on ventriculo-arterial coupling (VAC) in ATTRwt-CM is lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To describe ventriculo-arterial coupling (VAC) and its clinical correlates in a contemporary cohort of patients with ATTRwt-CM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The VAC, defined as the ratio between arterial (\n                      <jats:italic>E<\/jats:italic>\n                      <jats:sub>\n                        <jats:italic>a<\/jats:italic>\n                      <\/jats:sub>\n                      ) and ventricular elastance (\n                      <jats:italic>E<\/jats:italic>\n                      <jats:sub>\n                        <jats:italic>es<\/jats:italic>\n                      <\/jats:sub>\n                      ) was evaluated noninvasively using the single-beat algorithm based on arm cuff blood pressure, Doppler stroke volume, pre-ejection time and total ejection time.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study included 114 patients treated with the transthyretin stabilizer tafamidis from a national referral centre (median age 79\u00a0years; 89% males). Median values were 1.48 (1.22\u20131.84) mmHg\/ml for\n                      <jats:italic>E<\/jats:italic>\n                      <jats:sub>\n                        <jats:italic>a<\/jats:italic>\n                      <\/jats:sub>\n                      , 1.86 (1.49\u20132.29) mmHg\/ml for\n                      <jats:italic>E<\/jats:italic>\n                      <jats:sub>\n                        <jats:italic>es<\/jats:italic>\n                      <\/jats:sub>\n                      , and 1.24 (0.96\u20131.58) for VAC. Patients with upper-tertile VAC showed worse clinical (National Amyloidosis Centre (NAC)\/Mondor stage,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), laboratory (NT-pro-B-type natriuretic peptide levels,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), instrumental features (left ventricular ejection fraction and stroke volume,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0001 for both), and they received more intensive heart failure supportive therapies. The\n                      <jats:italic>E<\/jats:italic>\n                      <jats:sub>\n                        <jats:italic>a<\/jats:italic>\n                      <\/jats:sub>\n                      \/\n                      <jats:italic>E<\/jats:italic>\n                      <jats:sub>\n                        <jats:italic>es<\/jats:italic>\n                      <\/jats:sub>\n                      ratio, but not its single components, was associated with NT-proBNP levels. Finally, the\n                      <jats:italic>E<\/jats:italic>\n                      <jats:sub>\n                        <jats:italic>a<\/jats:italic>\n                      <\/jats:sub>\n                      \/\n                      <jats:italic>E<\/jats:italic>\n                      <jats:sub>\n                        <jats:italic>es<\/jats:italic>\n                      <\/jats:sub>\n                      ratio was an independent determinant of a high NAC\/Mondor stage at both univariate (OR[95% CI]:15.39[3.51\u201367.35],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and multivariate (OR[95% CI]:11.26[1.98\u201363.81],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006) logistic regression analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In ATTRwt-CM patients, arterial and ventricular elastances and VAC are independent predictors of worse clinical status and more advanced disease stage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00392-025-02727-z","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T07:01:47Z","timestamp":1762239707000},"page":"811-825","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Left ventriculo-arterial coupling in a contemporary cohort of patients with wild-type transthyretin cardiac amyloidosis treated with tafamidis"],"prefix":"10.1007","volume":"115","author":[{"given":"Giuseppe Damiano","family":"Sanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria Anna","family":"Di Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Fogliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Mussinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Guida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Attanasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Obici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Basset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Nanci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Foli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavino","family":"Casu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Nuvolone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Merlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0320-8574","authenticated-orcid":false,"given":"Stefano","family":"Perlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Palladini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"issue":"45","key":"2727_CR1","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1093\/eurheartj\/ehac543","volume":"43","author":"C Rapezzi","year":"2022","unstructured":"Rapezzi C, Aimo A, Barison A, Emdin M, Porcari A, Linhart A et al (2022) Restrictive cardiomyopathy: definition and diagnosis. Eur Heart J 43(45):4679\u20134693. https:\/\/doi.org\/10.1093\/eurheartj\/ehac543","journal-title":"Eur Heart J"},{"issue":"31","key":"2727_CR2","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehad347","volume":"44","author":"A Ioannou","year":"2023","unstructured":"Ioannou A, Massa P, Patel RK, Razvi Y, Porcari A, Rauf MU et al (2023) Conventional heart failure therapy in cardiac ATTR amyloidosis. Eur Heart J 44(31):2893\u20132907. https:\/\/doi.org\/10.1093\/eurheartj\/ehad347","journal-title":"Eur Heart J"},{"issue":"3","key":"2727_CR3","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1161\/01.res.32.3.314","volume":"32","author":"H Suga","year":"1973","unstructured":"Suga H, Sagawa K, Shoukas AA (1973) Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of epinephrine and heart rate on the ratio. Circ Res 32(3):314\u2013322. https:\/\/doi.org\/10.1161\/01.res.32.3.314","journal-title":"Circ Res"},{"issue":"1","key":"2727_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/01.res.35.1.117","volume":"35","author":"H Suga","year":"1974","unstructured":"Suga H, Sagawa K (1974) Instantaneous pressure-volume relationships and their ratio in the excised, supported canine left ventricle. Circ Res 35(1):117\u2013126. https:\/\/doi.org\/10.1161\/01.res.35.1.117","journal-title":"Circ Res"},{"issue":"5","key":"2727_CR5","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/01.res.43.5.677","volume":"43","author":"K Sagawa","year":"1978","unstructured":"Sagawa K (1978) The ventricular pressure-volume diagram revisited. Circ Res 43(5):677\u2013687. https:\/\/doi.org\/10.1161\/01.res.43.5.677","journal-title":"Circ Res"},{"issue":"6","key":"2727_CR6","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1161\/01.cir.63.6.1223","volume":"63","author":"K Sagawa","year":"1981","unstructured":"Sagawa K (1981) The end-systolic pressure-volume relation of the ventricle: definition, modifications and clinical use. Circulation 63(6):1223\u20131227. https:\/\/doi.org\/10.1161\/01.cir.63.6.1223","journal-title":"Circulation"},{"issue":"5 Pt 1","key":"2727_CR7","doi-asserted-by":"publisher","first-page":"H773","DOI":"10.1152\/ajpheart.1983.245.5.H773","volume":"245","author":"K Sunagawa","year":"1983","unstructured":"Sunagawa K, Maughan WL, Burkhoff D, Sagawa K (1983) Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol 245(5 Pt 1):H773-8048. https:\/\/doi.org\/10.1152\/ajpheart.1983.245.5.H773","journal-title":"Am J Physiol"},{"issue":"4","key":"2727_CR8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/01.res.56.4.586","volume":"56","author":"K Sunagawa","year":"1985","unstructured":"Sunagawa K, Maughan WL, Sagawa K (1985) Optimal arterial resistance for the maximal stroke work studied in isolated canine left ventricle. Circ Res 56(4):586\u2013595. https:\/\/doi.org\/10.1161\/01.res.56.4.586","journal-title":"Circ Res"},{"key":"2727_CR9","doi-asserted-by":"publisher","unstructured":"Chirinos JA (2013) Ventricular-arterial coupling: invasive and non-invasive assessment. Artery Res 7(1):https:\/\/doi.org\/10.1016\/j.artres.2012.12.002.","DOI":"10.1016\/j.artres.2012.12.002"},{"issue":"6 Pt 2","key":"2727_CR10","doi-asserted-by":"publisher","first-page":"H1817","DOI":"10.1152\/ajpheart.1993.264.6.H1817","volume":"264","author":"PP De Tombe","year":"1993","unstructured":"De Tombe PP, Jones S, Burkhoff D, Hunter WC, Kass DA (1993) Ventricular stroke work and efficiency both remain nearly optimal despite altered vascular loading. Am J Physiol 264(6 Pt 2):H1817\u2013H1824. https:\/\/doi.org\/10.1152\/ajpheart.1993.264.6.H1817","journal-title":"Am J Physiol"},{"issue":"7","key":"2727_CR11","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/s0735-1097(01)01651-5","volume":"38","author":"CH Chen","year":"2001","unstructured":"Chen CH, Fetics B, Nevo E, Rochitte CE, Chiou KR, Ding PA et al (2001) Noninvasive single-beat determination of left ventricular end-systolic elastance in humans. J Am Coll Cardiol 38(7):2028\u20132034. https:\/\/doi.org\/10.1016\/s0735-1097(01)01651-5","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"2727_CR12","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.jacc.2013.03.085","volume":"62","author":"B Ky","year":"2013","unstructured":"Ky B, French B, May Khan A, Plappert T, Wang A, Chirinos JA et al (2013) Ventricular-arterial coupling, remodeling, and prognosis in chronic heart failure. J Am Coll Cardiol 62(13):1165\u20131172. https:\/\/doi.org\/10.1016\/j.jacc.2013.03.085","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2727_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4103\/2211-4122.127408","volume":"23","author":"F Antonini-Canterin","year":"2013","unstructured":"Antonini-Canterin F, Poli S, Vriz O, Pavan D, Bello VD, Nicolosi GL (2013) The ventricular-arterial coupling: from basic pathophysiology to clinical application in the echocardiography laboratory. J Cardiovasc Echogr 23(4):91\u201395. https:\/\/doi.org\/10.4103\/2211-4122.127408","journal-title":"J Cardiovasc Echogr"},{"key":"2727_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2019.04.052","volume":"288","author":"P Trambaiolo","year":"2019","unstructured":"Trambaiolo P, Bertini P, Borrelli N, Poli M, Romano S, Ferraiuolo G et al (2019) Evaluation of ventriculo-arterial coupling in ST elevation myocardial infarction with left ventricular dysfunction treated with levosimendan. Int J Cardiol 288:1\u20134. https:\/\/doi.org\/10.1016\/j.ijcard.2019.04.052","journal-title":"Int J Cardiol"},{"key":"2727_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ijcard.2021.12.026","volume":"348","author":"P Trambaiolo","year":"2022","unstructured":"Trambaiolo P, Figliuzzi I, Salvati M, Bertini P, Brizzi G, Tocci G et al (2022) Ventriculo-arterial coupling in the intensive cardiac care unit: a non-invasive prognostic parameter. Int J Cardiol 348:85\u201389. https:\/\/doi.org\/10.1016\/j.ijcard.2021.12.026","journal-title":"Int J Cardiol"},{"issue":"11","key":"2727_CR16","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","volume":"379","author":"MS Maurer","year":"2018","unstructured":"Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M et al (2018) Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 379(11):1007\u20131016. https:\/\/doi.org\/10.1056\/NEJMoa1805689","journal-title":"N Engl J Med"},{"issue":"11","key":"2727_CR17","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","volume":"81","author":"MM Kittleson","year":"2023","unstructured":"Kittleson MM, Ruberg FL, Ambardekar AV, Brannagan TH, Cheng RK, Clarke JO et al (2023) 2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the american college of cardiology solution set oversight committee. J Am Coll Cardiol 81(11):1076\u20131126. https:\/\/doi.org\/10.1016\/j.jacc.2022.11.022","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2727_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/13506129.2024.2374904","volume":"31","author":"P Milani","year":"2024","unstructured":"Milani P, Fabris F, Mussinelli R, Sanna GD, Basset M, Benvenuti P et al (2024) Delayed identification of monoclonal protein is associated with early death in isolated cardiac AL amyloidosis. Amyloid 31(3):220\u2013225. https:\/\/doi.org\/10.1080\/13506129.2024.2374904","journal-title":"Amyloid"},{"issue":"9","key":"2727_CR19","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","volume":"48","author":"JA Katzmann","year":"2002","unstructured":"Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR et al (2002) Serum Reference Intervals and Diagnostic Ranges for Free \u03ba and Free \u03bb Immunoglobulin Light Chains: Relative Sensitivity for Detection of Monoclonal Light Chains. Clin Chem 48(9):1437\u20131444","journal-title":"Clin Chem"},{"issue":"3","key":"2727_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1161\/CIRCULATIONAHA.124.072460","volume":"151","author":"MU Nuvolone","year":"2025","unstructured":"Nuvolone MU, Sanna GD, Palladini G (2025) AL or ATTR amyloidosis? Never two without three. Circulation 151(3):274\u2013281. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.072460","journal-title":"Circulation"},{"issue":"30","key":"2727_CR21","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","volume":"39","author":"JD Gillmore","year":"2018","unstructured":"Gillmore JD, Damy T, Fontana M, Hutchinson M, Lachmann HJ, Martinez-Naharro A et al (2018) A new staging system for cardiac transthyretin amyloidosis. Eur Heart J 39(30):2799\u20132806. https:\/\/doi.org\/10.1093\/eurheartj\/ehx589","journal-title":"Eur Heart J"},{"issue":"4","key":"2727_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.tcm.2023.02.006","volume":"34","author":"N Martini","year":"2024","unstructured":"Martini N, Sinigiani G, De Michieli L, Mussinelli R, Perazzolo Marra M, Iliceto S et al (2024) Electrocardiographic features and rhythm disorders in cardiac amyloidosis. Trends Cardiovasc Med 34(4):257\u2013264. https:\/\/doi.org\/10.1016\/j.tcm.2023.02.006","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"2727_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the american society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr 28(1):1-39.e14. https:\/\/doi.org\/10.1016\/j.echo.2014.10.003","journal-title":"J Am Soc Echocardiogr"},{"issue":"4","key":"2727_CR24","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/ejhf.2456","volume":"24","author":"H Holm","year":"2022","unstructured":"Holm H, Magnusson M, Juji\u0107 A, Bozec E, Girerd N (2022) How to calculate ventricular-arterial coupling? Eur J Heart Fail 24(4):600\u2013602. https:\/\/doi.org\/10.1002\/ejhf.2456","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"2727_CR25","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jaccao.2021.08.007","volume":"3","author":"RH Falk","year":"2021","unstructured":"Falk RH, Haddad M, Walker CR, Dorbala S, Cuddy SAM (2021) Effect of tafamidis on serum transthyretin levels in non-trial patients with transthyretin amyloid cardiomyopathy. JACC CardioOncol 3(4):580\u2013586. https:\/\/doi.org\/10.1016\/j.jaccao.2021.08.007","journal-title":"JACC CardioOncol"},{"issue":"14","key":"2727_CR26","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.jacc.2023.12.036","volume":"83","author":"A Ioannou","year":"2024","unstructured":"Ioannou A, Cappelli F, Emdin M, Nitsche C, Longhi S, Masri A et al (2024) Stratifying disease progression in patients with cardiac ATTR amyloidosis. J Am Coll Cardiol 83(14):1276\u20131291. https:\/\/doi.org\/10.1016\/j.jacc.2023.12.036","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2727_CR27","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1093\/ehjci\/jead145","volume":"24","author":"D Tomasoni","year":"2023","unstructured":"Tomasoni D, Adamo M, Porcari A, Aimo A, Bonfioli GB, Castiglione V et al (2023) Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis. Eur Heart J Cardiovasc Imaging 24(10):1405\u20131414. https:\/\/doi.org\/10.1093\/ehjci\/jead145","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2727_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2023.131147","volume":"388","author":"G Palmiero","year":"2023","unstructured":"Palmiero G, Monda E, Verrillo F, Dongiglio F, Caiazza M, Rubino M et al (2023) Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis. Int J Cardiol 388:131147. https:\/\/doi.org\/10.1016\/j.ijcard.2023.131147","journal-title":"Int J Cardiol"},{"key":"2727_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-024-02576-2","author":"SK Schwarting","year":"2024","unstructured":"Schwarting SK, Poledniczek M, Metodiev Y, Stolz L, Hofmann E, Hegenbart U et al (2024) RV-PA uncoupling is associated with increased mortality in transthyretin amyloid cardiomyopathy treated with tafamidis. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-024-02576-2","journal-title":"Clin Res Cardiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02727-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-025-02727-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02727-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:55:43Z","timestamp":1776236143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-025-02727-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2727"],"URL":"https:\/\/doi.org\/10.1007\/s00392-025-02727-z","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GDS\u2014Cardiac ATTR Amyloidosis Fellowship grant funded by the International Society of Amyloidosis; honoraria from Pfizer, and AstraZeneca; PM has received honoraria from Janssen, Prothena, Pfizer (also research grant) and Siemens (also served on advisory board); MN has received honoraria from Janssen, Prothena, Pfizer (also research grant), and Argobio and has served on advisory board and received research grant from Gate Bioscience; SP received honoraria from Pfizer, Alnylam and served on advisory boards Pfizer and Prothena; GP received honoraria from Pfizer, Sebia, and Siemens and served on advisory boards Alexion, Argobio, GSK, Janssen, and Prothena.The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}